Literature DB >> 30724632

E2F1 as a molecular drug target in ovarian cancer.

Rossella Farra1, Barbara Dapas1, Mario Grassi2, Fabio Benedetti3, Gabriele Grassi1.   

Abstract

Entities:  

Keywords:  E2F1; Ovarian cancer; PIN-1; cyclinD1

Mesh：

Substances：

Year:  2019        PMID： 30724632     DOI： 10.1080/14728222.2019.1579797

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN： 1472-8222            Impact factor:   6.902


× No keyword cloud information.
  9 in total

1.  Regulation of the transcription factor E2F1 mRNA in ovarian granulosa cells of cattle.

Authors:  Breanne C Morrell; M Chiara Perego; Excel Rio S Maylem; Lingna Zhang; Luis F Schütz; Leon J Spicer
Journal:  J Anim Sci       Date:  2020-01-01       Impact factor: 3.159

2.  A Novel Transcription Factor-Based Prognostic Signature in Endometrial Cancer: Establishment and Validation.

Authors:  Xiao Yang; Yuan Cheng; Xingchen Li; Jingyi Zhou; Yangyang Dong; Boqiang Shen; Lijun Zhao; Jianliu Wang
Journal:  Onco Targets Ther       Date:  2021-04-13       Impact factor: 4.147

3.  xCT contributes to colorectal cancer tumorigenesis through upregulation of the MELK oncogene and activation of the AKT/mTOR cascade.

Authors:  Bufu Tang; Jinyu Zhu; Fangming Liu; Jiayi Ding; Yajie Wang; Shiji Fang; Liyun Zheng; Rongfang Qiu; Minjiang Chen; Gaofeng Shu; Min Xu; Chenying Lu; Zhongwei Zhao; Yang Yang; Jiansong Ji
Journal:  Cell Death Dis       Date:  2022-04-19       Impact factor: 9.685

Review 4.  Strategies for Delivery of siRNAs to Ovarian Cancer Cells.

Authors:  Rossella Farra; Matea Maruna; Francesca Perrone; Mario Grassi; Fabio Benedetti; Marianna Maddaloni; Maguie El Boustani; Salvo Parisi; Flavio Rizzolio; Giancarlo Forte; Fabrizio Zanconati; Maja Cemazar; Urska Kamensek; Barbara Dapas; Gabriele Grassi
Journal:  Pharmaceutics       Date:  2019-10-22       Impact factor: 6.321

Review 5.  [Advancement of E2F1 in Common Tumors].

Authors:  Cheng Shen; Jue Li; Shuai Chang; Guowei Che
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-10-20

6.  Pan-Cancer Molecular Patterns and Biological Implications Associated with a Tumor-Specific Molecular Signature.

Authors:  Darío Rocha; Iris A García; Aldana González Montoro; Andrea Llera; Laura Prato; María R Girotti; Gastón Soria; Elmer A Fernández
Journal:  Cells       Date:  2020-12-31       Impact factor: 6.600

7.  Oncogenic B-Myb Is Associated With Deregulation of the DREAM-Mediated Cell Cycle Gene Expression Program in High Grade Serous Ovarian Carcinoma Clinical Tumor Samples.

Authors:  Audra N Iness; Lisa Rubinsak; Steven J Meas; Jessica Chaoul; Sadia Sayeed; Raghavendra Pillappa; Sarah M Temkin; Mikhail G Dozmorov; Larisa Litovchick
Journal:  Front Oncol       Date:  2021-03-04       Impact factor: 6.244

8.  POLD2 is activated by E2F1 to promote triple-negative breast cancer proliferation.

Authors:  Zhen Zhang
Journal:  Front Oncol       Date:  2022-09-02       Impact factor: 5.738

9.  MCTS1 promotes the development of lung adenocarcinoma by regulating E2F1 expression.

Authors:  Cun Gao; Rui Dong; Yongmeng Li; Jinghui Liang; Hui Tian
Journal:  Oncol Lett       Date:  2021-05-17       Impact factor: 2.967
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.